Upload
omar-sexton
View
55
Download
1
Tags:
Embed Size (px)
DESCRIPTION
Sarcoidosis in Turkey. Dr.Göksel KITER Pamukkale University, Medical Faculty Pulmonary Medicine Department. Main topics. Overview to the studies on Turkish Sarcoidosis cases “Sarcoidosis” study preformed by Turkish Thoracic Society The results obtained from that study - PowerPoint PPT Presentation
Citation preview
Sarcoidosis in TurkeySarcoidosis in Turkey
Dr.Göksel KITERDr.Göksel KITER
Pamukkale University, Medical Pamukkale University, Medical Faculty Faculty
Pulmonary Medicine DepartmentPulmonary Medicine Department
Main topicsMain topics
Overview to the studies on Turkish Overview to the studies on Turkish Sarcoidosis casesSarcoidosis cases
““Sarcoidosis” study preformed by Turkish Sarcoidosis” study preformed by Turkish Thoracic SocietyThoracic Society
The results obtained from that studyThe results obtained from that study
Lessons that we’ve learned in that processLessons that we’ve learned in that process
ACCESSACCESS
Case control studyCase control study Aimed to evaluate the etiological aspectAimed to evaluate the etiological aspect November 1996-June 1999November 1996-June 1999 10 centers; 720 patients and 720 controls10 centers; 720 patients and 720 controls
Turkish Sarcoidosis Case Turkish Sarcoidosis Case SeriesSeries
Gürkan ÖU, Çelik G, Kumbasar Ö ve ark. Sarcoidosis in Turkey:1954-2000. Ann Saudi Med Gürkan ÖU, Çelik G, Kumbasar Ö ve ark. Sarcoidosis in Turkey:1954-2000. Ann Saudi Med 2004 2004
Tabak L, Kılıçarslan Z, Kıyan E ve ark. 147 sarkoidoz hastasının klinik özellikleri. Solunum Tabak L, Kılıçarslan Z, Kıyan E ve ark. 147 sarkoidoz hastasının klinik özellikleri. Solunum 20012001
Sağlam L, Kaynar H, Akgün M ve ark. The retrospective analysis of our patients with Sağlam L, Kaynar H, Akgün M ve ark. The retrospective analysis of our patients with sarcoidosis. 2001sarcoidosis. 2001
Aytemur ZA, Erdinç M, Erdinç E, ve ark. Sarkoidozda evrelere göre klinik özellikler ve tanısal Aytemur ZA, Erdinç M, Erdinç E, ve ark. Sarkoidozda evrelere göre klinik özellikler ve tanısal yaklaşım. Tüberküloz ve Toraks 2003yaklaşım. Tüberküloz ve Toraks 2003
Yalnız E, Kömürcüoğlu A, Polat GE, ve ark. Sarkoidozda klinik, radyolojik, laboratuarla ilgili Yalnız E, Kömürcüoğlu A, Polat GE, ve ark. Sarkoidozda klinik, radyolojik, laboratuarla ilgili parametreler ve tanı yöntemleri. Toraks Dergisi 2003parametreler ve tanı yöntemleri. Toraks Dergisi 2003
Erbaycu AE, Uçar ZZ, Çakan A, ve ark. Seasonal clustering of sarcoidosis in spring in Turkey. Erbaycu AE, Uçar ZZ, Çakan A, ve ark. Seasonal clustering of sarcoidosis in spring in Turkey. Turkish Respiratory Journal, 2004.Turkish Respiratory Journal, 2004.
Baran A, Özşeker F, Güneylioğlu D, ve ark. Sarkoidoz: Yedi yıllık deneyim. Toraks Dergisi Baran A, Özşeker F, Güneylioğlu D, ve ark. Sarkoidoz: Yedi yıllık deneyim. Toraks Dergisi 20042004
Demirkök SS, Başaranoğlu M, Akıncı ED, Karayel T. Analysis of 275 patients with sarcoidosis Demirkök SS, Başaranoğlu M, Akıncı ED, Karayel T. Analysis of 275 patients with sarcoidosis over a 38 year period; a single-instutition experience. Respiratory Medicine 2006over a 38 year period; a single-instutition experience. Respiratory Medicine 2006
1954-20001954-20001327 patients from 29 1327 patients from 29 seriesseries 1990-2000, Istanbul 1990-2000, Istanbul
Medical Faculty; 147 Medical Faculty; 147 casescases1991-2002, Erzurum, 1991-2002, Erzurum,
Atatürk University; 25 Atatürk University; 25 casescases 1990-1998, Izmir, Ege 1990-1998, Izmir, Ege
University; 77 casesUniversity; 77 cases1995-2001, Izmir Chest 1995-2001, Izmir Chest Hospital; 73 casesHospital; 73 cases
1994-2003, Izmir Chest 1994-2003, Izmir Chest hospital; 86 caseshospital; 86 cases
1994-2000, Istanbul 1994-2000, Istanbul Sureyyapasa Chest Sureyyapasa Chest Hospital; 70 casesHospital; 70 cases 1966-2004, Istanbul 1966-2004, Istanbul
Cerrahpasa Medical Cerrahpasa Medical Faculty; 275 casesFaculty; 275 cases
Gürkan Tabak Sağlam Aytemur Yalnız Erbaycu Baran Demirkök
N 1327 147 25 77 73 86 70 275
M/F 1,8 2,1 2,1 2,3 2,7 5,1 3,1 2,2
Age 30-48 39±13 38±13 43 45±13 45±16 44±12 40±13
Nonsmoker %70 %71,5
Gürkan Tabak Sağlam Aytemur Yalnız Erbaycu Baran Demirkök
EN 10 29 38 26 15 11 29
Skin 1,6 5 3 5 19 26
Eye 5 10 0 5 3 8 7 11
Peripheral LAP 9 1 11 4 68 6 19
HM 5 4 6 7
SM 3,5 3 3 6
Heart 2 3 1
Nervous 1 2 3,6 5 3
Renal 1,3
Joint 2 0 8 27
Parotid gland 4 0 1,4 7
Turkish Thoracic Society Turkish Thoracic Society Clinical Problems Working Clinical Problems Working
GroupGroup““Sarcoidosis” studySarcoidosis” study
Aim of the studyAim of the study
To find-out the epidemiological features of To find-out the epidemiological features of sarcoidosis in Turkeysarcoidosis in Turkey
To evaluate the pulmonary involvementTo evaluate the pulmonary involvement
To evaluate the utility of diagnostic approachsTo evaluate the utility of diagnostic approachs
To assess the extra-pulmonary involvementTo assess the extra-pulmonary involvement
To make a comment on geographical disturbanceTo make a comment on geographical disturbance
1 June 2004 – 31 May 20061 June 2004 – 31 May 2006
12 cities, 19 centers, 24 12 cities, 19 centers, 24 colleaguescolleagues
293 new patients 293 new patients
SymptomsSymptomsSymptom N %
Cough 156 53.2
Dyspnea 118 40.3
Sputum 40 13.7
Hemopthysis 7 2.4
Chest pain 66 22.5
PULMONARY (Total) 216 73.7
Fatigue 113 38.6
Weight loss 53 18.1
Fever 39 13.3
Night sweating 7 2.3
CONSTITUTIONAL (Total) 148 50.5
Symptom N %
Erythema nodosum 63 21.5
Joint pain 61 20.8
Back pain 48 16.4
Skin lesion 47 16
Joint swelling 17 5.8
Myalgia 14 4.8
Ocular findings 9 3.1
Head ache 9 3.1
Mass in neck 8 2.7
Bone pain 6 2
Sweating 6 2
Dyspepsia 5 1.7
Paresthesia 5 1.7
Diarrhea 4 1.4
Difficulty in movements 3 1
Dry mouth 3 1
Palpitation 2 0.7
Dizziness 2 0.7
Subcutaneous mass 1 0.3
Dry eye 1 0.3
Other 12 4
EXTRAPULMONARY (total) 181 61.8
Extrapulmonary Symptom N %
Erythema nodosum 63 21.5
Joint pain 61 20.8
Back pain 48 16.4
Skin lesion 47 16
Joint swelling 17 5.8
Myalgia 14 4.8
Ocular findings 9 3.1
Head ache 9 3.1
Mass in neck 8 2.7
Bone pain 6 2
Sweating 6 2
Sign N %
Erythema nodosum 50 17,1
Inspiratory crackles 36 12,3
Peripheral LAM 33 11,3
Splenomegaly 12 4,1
Hepatomegaly 11 3,8
Wheezing 10 3,4
Parotis gland enlargement 4 1,4
Cyanosis 1 0,3
Radiological finding N %
Hilar lymphadenomegaly 263 89.8
Bilateral 231 78.8
Right 26 8.9
Left 6 2.0
Nodular involvement 98 33.4
Paratracheal lymphadenomegaly
75 25.6
Reticular infiltration 31 10.6
Pleurisy 5 1.7
Pneumothorax 7 2.4
Honey combing 2 0.7
Normal 14 4.8
Radiological stageRadiological stage
Stage n %
Stage 0 14 4.8
Stage I 152 51.9
Stage II 110 37.5
Stage III 15 5.1
Stage IV 2 0.7
CT findings N %
Mediastinal lymphadenomegaly 270 92.2
Nodules 143 48.8
Reticular infiltration 62 21.2
Ground-glass apperence 50 17.1
Alveolar sarcoidosis 13 4.4
Pleural calsification 13 4.4
Calsified lymphadenomegaly 12 4.1
Bronchiectases 9 3.1
Diffuse fibrosis 8 2.7
Pleurisy 8 2.7
Air-trapping 7 2.4
Honey combing 5 1.7
Cavity 1 0.3
CT not performed 7 2.4
Parameter Mean ± SD %pred.
FVC 3198 ± 1179 92.2 ± 42.8
FEV1 2546 ± 946 86.1 ± 19.0
FEV1/FVC 81.3 ± 11.1
MMEF 2.7 ± 1.4 71.0 ± 28.8
DLco 20.5 ± 8.5 82.6 ± 21.3
DLco/VA 4.4 ± 1.3 95.5 ± 23.0
PFT was performed in 257 patients, CO diffusion test was performed in 161 patients
Gurkan OU, Celik G, Kumbasar O et al. Gurkan OU, Celik G, Kumbasar O et al. Sarcoidosis in Turkey:1954-2000. Ann Saudi Sarcoidosis in Turkey:1954-2000. Ann Saudi
Med 2004 Med 2004
Bronchoscopic findings N %
Mucosal hyperemia 46 19.8
External bronchial compression 39 16.8
Nodular lesion 14 6.0
Mucosal infiltration 14 6.0
Bronchoconstriction 2 0.9
Intrabronchial mass 1 0.4
No abnormal finding 86 37.1
Bronchoscopy not performed 62 21.1
BALF analysesBALF analyses
In 79 sarcoidosis patients (26.9%)In 79 sarcoidosis patients (26.9%) Lymphocytic plus neutrofilic alveolitis Lymphocytic plus neutrofilic alveolitis
46.8%46.8% Lone lymphocytic alveolitis 34.2% Lone lymphocytic alveolitis 34.2% Lone neutrophilic alveolitis 5.1%Lone neutrophilic alveolitis 5.1% Mixt alveolitis 5.1%Mixt alveolitis 5.1% No alveolitis 8.9% No alveolitis 8.9%
Only Neutrophilic plus lymphositic Only Neutrophilic plus lymphositic alveolitis was found associated with only alveolitis was found associated with only being recently active smoker (p=0.03). being recently active smoker (p=0.03).
Demirkök SS, Başaranoğlu M, Akıncı ED, Demirkök SS, Başaranoğlu M, Akıncı ED, Karayel T. Analysis of 275 patients with Karayel T. Analysis of 275 patients with
sarcoidosis over a 38 year period; a single-sarcoidosis over a 38 year period; a single-instutition experience. Respiratory Medicine instutition experience. Respiratory Medicine
20062006
Sampling method N % Success rate
Transbronchial biopsy 127 43.3 48.8
Bronchial mucosa biopsy 95 32.4 52.6
Mediastinoscopy 90 30.7 100.0
Transbronchial needle aspiration
68 23.2 44.1
Skin biopsy 28 9.6 75.0
Peripheral lymph node biopsy
18 6.1 94.4
Scalen lymph node biopsy 12 4.1 83.3
Open lung biopsy 9 3.1 88.9
Mediastinotomy 5 1.7 100.0
VATS 3 1.0 100.0
Transthoracic biopsy 2 0.7 100.0
ACCESSACCESS LiteratureLiterature
%% %%
LungLung 99,099,0 95,095,0 9090
Erythema nodosumErythema nodosum 22,022,0 8,28,2 3-253-25
Skin except Erythema nodosumSkin except Erythema nodosum 16,416,4 15,915,9 10-3510-35
Peripheral lymph nodePeripheral lymph node 13,813,8 15,215,2 1515
JointJoint 6,86,8 0,50,5 25-3925-39
Eye*Eye* 5,95,9 11,811,8 25-6025-60
Neurolojic systemNeurolojic system 3,33,3 4,64,6 5-125-12
HeartHeart 3,33,3 2,32,3 55
Saliva gland and parotisSaliva gland and parotis 14,314,3 3,93,9 1010
Tyroid glandTyroid gland 2,62,6 00 44
Upper air wayUpper air way 1,11,1 3,03,0 99
RenalRenal 0,90,9 0,70,7 44* More
in above age 40
Older patients were mostly living at sea-side cities; p=0,006
GEOGRAPHIC DIFFERENCESGEOGRAPHIC DIFFERENCES
ConclusionConclusion Turkish sarcoidosis cases, especially females, were older Turkish sarcoidosis cases, especially females, were older
than the literature. Female/male=2than the literature. Female/male=2
Smokers were in 20%; similar to published dataSmokers were in 20%; similar to published data
Pulmonary symptoms were frequent (Cough the most)Pulmonary symptoms were frequent (Cough the most)
Constitutional symptoms in half of the patients (fever the Constitutional symptoms in half of the patients (fever the most)most)
Lower eye and neurological involvement ratiosLower eye and neurological involvement ratios
Elderly patients in the areas near to the seaElderly patients in the areas near to the sea
Histopathological confirmation rate was high (%90,4); Histopathological confirmation rate was high (%90,4); bronchoscopy was yielded in half of the patients, bronchoscopy was yielded in half of the patients, mediastinoscopy was used not very rarely.mediastinoscopy was used not very rarely.
LESSONS WE’VE LEARNEDLESSONS WE’VE LEARNED It should be forced to include patients It should be forced to include patients
representing all geographic areas.representing all geographic areas. All physicians should be attend to the study.All physicians should be attend to the study. 2.5 fold attendence to ILD study.2.5 fold attendence to ILD study. Internet is a useful tool.Internet is a useful tool. Method must be described more precisely.Method must be described more precisely. That study design is worked very-well. That study design is worked very-well.
Valuable epidemiologic data have been Valuable epidemiologic data have been obtained.obtained.
A data base has been created for further A data base has been created for further studies on treatment and follow-up.studies on treatment and follow-up.